Inflammatory bowel disease and diabetes: Is there a link between them?

Patients with inflammatory bowel disease (IBD) are reported to have an increased risk of diabetes. IBD therapies may also modulate blood glucose substantially. These observations are indicative of mechanistic connection(s) between IBD and diabetes.

• Publication year

  2022

• Venue

  World Journal of Diabetes

• Publication date

  2022-02-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.4239/wjd.v13.i2.126PMID 35211249PMCID 8855140
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Effect of inflammatory bowel disease treatments on patients with diabetes mellitus

  2021cited by this paper
• Unravelling the involvement of gut microbiota in type 2 diabetes mellitus.

  2021cited by this paper
• Comorbidity of inflammatory bowel disease in children and adolescents with type 1 diabetes

  2020cited by this paper
• Inflammatory Bowel Disease Increases Risk of Type 2 Diabetes in a Nationwide Cohort Study.

  2020cited by this paper
• Enteroendocrine Hormone Secretion and Metabolic Control: Importance of the Region of the Gut Stimulation

  2020cited by this paper
• Roles of the Gut in Glucose Homeostasis

  2016cited by this paper
• GLP-1 Induces Barrier Protective Expression in Brunner's Glands and Regulates Colonic Inflammation

  2016cited by this paper
• Dipeptidyl peptidase-4 expression is reduced in Crohn's disease.

  2012cited by this paper
• GLP-1 receptor agonists for individualized treatment of type 2 diabetes mellitus

  2012cited by this paper
• Glucagon-like peptide-1 as a treatment for chemotherapy-induced mucositis

  2012cited by this paper
• Dysbiosis of the faecal microbiota in patients with Crohn's disease and their unaffected relatives

  2011cited by this paper
• Association of paediatric inflammatory bowel disease with other immune-mediated diseases

  2011cited by this paper
• New IBD genetics: common pathways with other diseases

  2011cited by this paper

• Characteristics, Complications, Comorbidities, and Other Manifestations of Inflammatory Bowel Disease: A 7-Year Tertiary Center Experience

  2026cites this paper
• Hyperglycemia alters the gene and protein expression of CDC42 in small and large intestine of Sprague-Dawley rats.

  2026cites this paper
• Dissecting the bidirectional associations between the progression of gastrointestinal and endocrine diseases

  2025cites this paper
• Pathomorphosis of ulcerative colitis: from body weight deficiency to sarcopenic obesity

  2024cites this paper
• Type II diabetes mellitus increases the risk of inflammatory bowel disease in a prospective cohort study.

  2024cites this paper
• Hyperglycemic environments directly compromise intestinal epithelial barrier function in an organoid model and hyaluronan (~35 kDa) protects via a layilin dependent mechanism

  2024cites this paper
• Eggplant (Solanum melongena L.) extract improves glucose uptake in LPS-induced inflammation in Caco-2/macrophages co-culture model

  2024cites this paper
• The inflammatory bowel disease and gut microbiome are restored by employing metformin-loaded alginate-shelled microcapsules.

  2024cites this paper
• Genome-wide cross-disease analyses highlight causality and shared biological pathways of type 2 diabetes with gastrointestinal disorders

  2024cites this paper
• Inpatient outcomes of inflammatory bowel disease in hospitalized patients with COVID-19: analysis of a nationally representative sample

  2024cites this paper
• Type 2 diabetes and inflammatory bowel disease: a bidirectional two-sample Mendelian randomization study

  2024cites this paper
• Prevalence of overweight and obesity in patients with ulcerative colitis: a case-control study

  2023cites this paper
• Bavachin and Corylifol A Improve Muscle Atrophy by Enhancing Mitochondria Quality Control in Type 2 Diabetic Mice

  2023influential citation
• Impact of Obesity on the Course of Management of Inflammatory Bowel Disease—A Review

  2022cites this paper